Search clinical trials for: PF-04950615 (RN316)
Total 1298 results
-
PfizerActive, not recruitingHemophilia BUnited States, Canada, Australia, Turkey
-
University of the Balearic IslandsFundació d'investigació Sanitària de les Illes Balears; Consejo Superior de...Completed
-
Yale UniversityNational Institute on Drug Abuse (NIDA); Medical University of South Carolina; Johns Hopkins University and other collaboratorsCompletedCannabis Use DisorderUnited States
-
PfizerCompletedHealthy ParticipantsUnited States
-
ShireTerminatedCrohn's DiseaseUnited States, Australia, Romania, Israel, Italy, Croatia, South Africa, Germany, Poland, United Kingdom, Austria, Japan, Lithuania, Netherlands, Russian Federation, Serbia
-
PfizerCompletedNeoplasms by Histologic TypeUnited States, Italy
-
PfizerCompletedHealthy VolunteersUnited States
-
PfizerCompletedGlucose Metabolism Disorders | Metabolic Diseases | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System DiseasesUnited States
-
Mike O'Callaghan Military HospitalCompletedDiabetes | Pre-DiabetesUnited States
-
University of California, BerkeleyAlcon ResearchCompleted
-
PfizerCompletedHealthy VolunteersUnited States
-
Centre Hospitalier St AnneEtablissement Public de Santé Barthélemy Durand; Groupe Hospitalier Paul GuiraudNot yet recruitingSchizophrenia; PsychosisFrance
-
PfizerRecruiting
-
PfizerCompletedCrohn's DiseaseUnited States, Denmark, Israel, Ireland, Australia, Czechia, Canada, United Kingdom, Hungary, Germany, New Zealand, Brazil, Switzerland, Belgium, France, Italy
-
Kathryn WagnerPfizerCompleted
-
PfizerCompletedPeripheral Vascular Disease | Raynaud's DiseaseSpain, United States, Czechia, Hungary, Poland, Korea, Republic of, Canada, Mexico, Germany, Colombia, Sweden
-
Conatus Pharmaceuticals Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA)TerminatedAlcoholic HepatitisUnited States
-
PfizerWithdrawnAdvanced EGFRm (Del 19 or L858R +/- T790M) NSCLC
-
PfizerTerminatedAdvanced Non-Hematologic MalignanciesUnited States, United Kingdom
-
PfizerTerminatedCachexiaUnited States
-
PfizerTerminatedUlcerative ColitisUnited States, Australia, Italy, Korea, Republic of, Belgium, Israel, Turkey, Saudi Arabia, Germany, Serbia
-
Bausch & Lomb IncorporatedCompletedPrimary Open Angle Glaucoma | Ocular HypertensionJapan
-
PfizerCompleted
-
PfizerCompletedDiabetes Mellitus, Type 2Taiwan, United States, Hungary, Canada, Slovakia, India, Bulgaria
-
PfizerActive, not recruitingEczema | Atopic Dermatitis | Eczema, Atopic | Atopic Dermatitis, UnspecifiedUnited States, Canada, Czechia, Poland
-
PfizerTerminatedDilated Cardiomyopathy | Lamin A/C Gene MutationUnited States, Spain, Canada, Belgium, Italy, Argentina, Mexico, Netherlands, Norway, United Kingdom
-
University of OxfordCompletedTreatment Resistant Depression | Depression, UnipolarUnited Kingdom
-
ShireTerminatedCrohn's DiseaseSpain, United States, Korea, Republic of, Hungary, Turkey, Belgium, Bulgaria, Argentina, Greece, New Zealand, Bosnia and Herzegovina, Colombia, Estonia, Ireland, Japan, Lebanon, Mexico, Portugal, Slovakia, Ukraine
-
PfizerJANSSEN Alzheimer Immunotherapy Research & Development, LLCCompletedAlzheimer's DiseaseUnited States, Korea, Republic of
-
Jules Bordet InstituteWithdrawnBreast CancerBelgium, France
-
Conatus Pharmaceuticals Inc.CompletedKidney Diseases | Renal Insufficiency | Renal Impairment | Kidney DiseaseUnited States
-
PfizerTerminatedType 2 Diabetes Mellitus (T2DM)United States
-
PfizerCompletedPhiladelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML)Singapore
-
PfizerCompletedHealthyUnited States
-
PfizerWithdrawnDementia | Alzheimer's Disease | Dimebon | Investigational Drug
-
PfizerCompletedMelanoma | Carcinoma, Renal Cell | Breast Neoplasms | Carcinoma, Non-Small-Cell Lung | Lymphoma, T-CellUnited States, Germany
-
PfizerCompletedDiabetes Mellitus, Type 2Canada, United States, Korea, Republic of, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
PfizerActive, not recruitingHealthy VolunteersUnited States, Belgium
-
M.D. Anderson Cancer CenterPfizer; ISA Pharmaceuticals B.V.CompletedOropharyngeal Cancer | Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites | Malignant Neoplasms of Lip Oral Cavity and PharynxUnited States
-
ShireCompletedCrohn's DiseaseKorea, Republic of, United States, Spain, France, Serbia, Netherlands, Germany, Japan, Austria, Belgium, Poland, Canada, Norway, Slovakia, South Africa
-
PfizerActive, not recruitingBreast Cancer | Small Cell Lung Cancer | Ovarian CancerUnited States, China, Japan, Mexico, Bulgaria, Argentina
-
PfizerTerminatedAdvanced Solid Tumors | Metastatic Solid TumorsUnited States
-
PfizerCompletedObesityUnited States, Taiwan, Canada, Japan
-
Medela AGCompleted
-
PfizerRecruitingMelanoma | Neoplasms | Renal Cell Carcinoma | Non-small-cell Lung Cancer | Squamous Cell Carcinoma of the Head and Neck | Urothelial Carcinoma | Colorectal Carcinoma | Ovarian CarcinomaPuerto Rico, Japan, United States
-
PETHEMA FoundationRecruitingMultiple Myeloma in RelapseSpain
-
PfizerAvailableMultiple MyelomaUnited States, Canada